Precision Medicine Market Size & Trends in Europe Estimated to Grow USD 40,487 Million By 2025: Facts & Factors

According to the [190+ Pages] research report; the Europe Precision Medicine Market in 2018 was approximately USD 17,132 Million. The market is expected to grow at a CAGR of 13.1% and is anticipated to reach around USD 40,487 Million by 2025. Top market players are Thermo Fisher Scientific, Cepheid, Intel Corporation, Randox Laboratories, Novartis, Almac Group, Illumina, Johnson & Johnson and others.


New York, NY, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Europe Precision Medicine Market By Technology (Big Data Analytics, Gene Sequencing, Companion Diagnostics, Bioinformatics, Drug Discovery, and Others), By End-User (Diagnostic Tool Companies, Clinical Labs, Healthcare IT/Big Data Companies, and Pharma & Biotech Companies), and By Application (Oncology, Respiratory, CNS, Immunology, and Others): Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2025”.

“According to the research study, the Europe Precision Medicine Market was estimated at USD 17,132 Million in 2018 and is expected to reach USD 40,487 Million by 2025. The Europe Precision Medicine Market is expected to grow at a compound annual growth rate (CAGR) of 13.1% from 2019 to 2025”.

Precision medicine is the medical prototype that recommends healthcare customization through therapies, medical decisions, products, and practices personalized to the individual patient healthcare or medical/clinical requirements. In the precision medicine model, diagnostic testing is utilized for choosing apt or alternate medical treatment mode depending on the patient’s genetic make-up or structure as well as cellular analysis. Tools used in precision medicine comprise analytics, molecular diagnostics, and imaging techniques.

Request Your Free Sample Report of Europe Precision Medicine Market @ https://www.fnfresearch.com/sample/europe-precision-medicine-market-by-technology-big-data-275  

(The free sample of this report is readily available on request).

Our Free Sample Report Includes:            

  • 2020 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 190+ Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of table & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Facts and Factors research methodology

(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)

Key Questions Answered in this Report

1) What was the impact of COVID-19 on the Precision Medicine Market?

2) What is the market size, share of the Precision Medicine Market?

3) Who are the top market players in Precision Medicine Market?

4) What will be the future market of the Precision Medicine Market?

Key Offerings:

  • Market Size & Forecast by Revenue | 2020−2027
  • Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
  • Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography
  • Competitive Landscape – Top key vendors and other prominent vendors

Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/europe-precision-medicine-market-by-technology-big-data-275     
        
(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Furthermore, precision medicine enhances health outcomes, minimizes toxicity, and raises cost-efficiency. It allows the patient to optimize disease management.

Top Market Players:

Some of the key players involved in the business include Thermo Fisher Scientific, Cepheid, Intel Corporation, Randox Laboratories, Novartis, Almac Group, Illumina, Johnson & Johnson, Qiagen, GE Healthcare, Roche, IBM, Laboratory Corporation of America Holdings, Abbott Laboratories, Biomrieux Sa, and Healthcore among others.

To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/europe-precision-medicine-market-by-technology-big-data-275

Growing requirement of enhancing patient outcome to impel the market growth in Europe

Patient outcomes are likely to be improved through the utility of precision drugs in the European continent. It comprises of medical institutes ready to make genetic testing & analytics tools and investors willing to compensate the drug costs. Apart from this, drug institutes in Europe are focusing on creating new personalized modes of treatments while companion diagnostics providers are concentrating on gathering data efficiently. Additionally, genetic analytics help in interpreting the outcomes of the clinical data of the patients.

Moreover, Europe has played a major role in steering the transformation of the healthcare industry through the effective delivery of patient care services. Apparently, the growing occurrence of cancer will enhance the demand for the product in Europe over the forecast period. However, high initial costs of the precision drugs can hamper the market growth during the period from 2019 to 2025. Nevertheless, the introduction of new techniques in precision medicine production will offer new growth avenues for the European market, thereby nullifying the negative impact of the hindrances on the market growth over the forecast period.

Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/europe-precision-medicine-market-by-technology-big-data-275

Big data analytics segment to register the highest CAGR over the forecast period

The big data analytics segment is set to record the highest growth rate of over 14% during the forecast timeline. The growth of the segment over the forecast timeline is due to constant learning arrangements and real-time knowledge outcomes.

Oncology segment to dominate the application landscape by 2025

The segmental growth over the period from 2019 to 2025 is owing to the launching of new initiatives in the region like the commitment made by the European society for medical oncology in order to aid and shape the emergence of pattern shifting in treating cancer.

Request Customized Copy of Report @ https://www.fnfresearch.com/customization/europe-precision-medicine-market-by-technology-big-data-275

(We customize your report according to your research need. Ask our sales team for report customization.)

Patient outcomes are likely to be improved through the utility of precision drugs in the European continent. It comprises of medical institutes ready to make genetic testing & analytics tools and investors willing to compensate the drug costs. Apart from this, drug institutes in Europe are focusing on creating new personalized modes of treatments while companion diagnostics providers are concentrating on gathering data efficiently. Additionally, genetic analytics help in interpreting the outcomes of the clinical data of the patients.

The Europe precision medicine industry is sectored based on technology, end-user, and application. Based on the technology, the industry is segregated into Big Data Analytics, Gene Sequencing, Companion Diagnostics, Bioinformatics, Drug Discovery, and Others, In terms of end-user, the precision medicine market in Europe is classified into Diagnostic Tool Companies, Clinical Labs, Healthcare IT/Big Data Companies, and Pharma & Biotech Companies. Application-wise the market is divided into Oncology, Respiratory, CNS, Immunology, and Others.

Browse the full “Europe Precision Medicine Market By Technology (Big Data Analytics, Gene Sequencing, Companion Diagnostics, Bioinformatics, Drug Discovery, and Others), By End-User(Diagnostic Tool Companies, Clinical Labs, Healthcare IT/Big Data Companies, and Pharma & Biotech Companies), and By Application (Oncology, Respiratory, CNS, Immunology, and Others): Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2025" report at https://www.fnfresearch.com/europe-precision-medicine-market-by-technology-big-data-275

Germany to lead the European precision medicine industry growth by 2025

The growth of the market in Germany is owing to large-scale deployments of precision medicine units along with myriad types of services offered by the healthcare firms in the country.

This report segments the Europe Precision Medicine market as follows:

Europe Precision Medicine Market: By Technology Analysis

  • Big Data Analytics
  • Gene Sequencing
  • Companion Diagnostics
  • Bioinformatics
  • Drug Discovery
  • Others

Europe Precision Medicine Market: By End-User Analysis

  • Diagnostic Tool Companies
  • Clinical Labs
  • Healthcare IT/Big Data Companies
  • Pharma & Biotech Companies

Europe Precision Medicine Market: By Application Analysis

  • Oncology
  • Respiratory
  • CNS
  • Immunology
  • Others

Key Features of Europe Precision Medicine Market Report:

  • Europe Precision Medicine Market structure: Overview, industry life cycle analysis, supply chain analysis
  • Europe Precision Medicine Market: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Europe Precision Medicine Market size, trend, and forecast analysis
  • Europe Precision Medicine Market segments’ trend and forecast
  • Europe Precision Medicine Market’s competitive landscapes: Market share, Product portfolio, New product launches, etc.
  • Europe Precision Medicine Market attractiveness and associated growth opportunities
  • Emerging Trends in the Europe Precision Medicine Market.
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Related Reports:

Organ Preservation Market: https://www.fnfresearch.com/global-organ-preservation-market-by-solution-university-of

RFID in Healthcare Market: https://www.fnfresearch.com/global-rfid-in-healthcare-market-by-component-tags

Bone Void Fillers Market: https://www.fnfresearch.com/bone-void-fillers-market-by-type-calcium-sulphate

Artificial Blood Vessels Market: https://www.fnfresearch.com/artificial-blood-vessels-market-by-type-polydioxanone-elastomer-525

Behavioral Health Market: https://www.fnfresearch.com/behavioral-health-market-by-disorder-type-anxiety-disorder-526

About Facts & Factors (FnF Research):

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch

Follow Us Twitter: https://twitter.com/fnfresearch

Contact Us:

Facts & Factors

USA: +1-347-989-3985

Email: sales@fnfresearch.com

Web: https://www.fnfresearch.com

Blog: http://fnfnewsblog.com